SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is a focal point of market discussion, driven by strong recent housing data like increased pending home sales and falling mortgage rates, alongside its strategic expansion into a broader homeownership platform. The community is fiercely divided, with many accumulating shares on current dips, confident in an impending rebound and profitability goals, while others debate short-term price pressures from tax-loss selling and market dynamics.

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Ekso Bionics Holdings Inc

Ekso Bionics is trending following news of a proposed business combination with Applied Digital's cloud computing business to form ChronoScale, a new AI platform. This strategic shift from a pure robotics company to an AI-focused entity is igniting passionate debate among the community, which is enthusiastic about potential NVIDIA ties and the AI sector's growth. However, significant concerns are also being voiced regarding the substantial dilution for existing shareholders and the overall value proposition of the deal.

DoubleZero is a high-performance global network of independently contributed links, purpose-built for blockchain and other distributed systems. It provides direct, low-latency routing that strengthens validator performance and supports faster, fairer participation worldwide.  2Z Tokens are used to access the network’s connectivity service, and, on the other side, reward network contributors and resource providers based on performance and reliability. 2Z Tokens can also be staked to enhance the security of the network.

DoubleZero

DoubleZero ($2Z) is trending amidst buzz over new listings on major crypto exchanges, driving significant trading volume and price surges. The community is actively discussing its fiber optics technology, with many anticipating substantial "altseason" gains and FOMO, while some express caution regarding its rapid volatility.

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

Mannatech Inc. (MTEX) is a top trending low-float stock experiencing intense community discussion around a potential short squeeze and parabolic breakout. Traders are actively accumulating, eyeing key resistance breaks for further upside, while others caution against the volatility inherent in such momentum plays.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences (GLSI) is trending following positive preliminary clinical trial data for its FLAMINGO-01 breast cancer immunotherapy, which indicated a significant reduction in recurrence rates. This, coupled with news of extended insider share lock-ups through September 2026, has fueled intense community discussion around a potential short squeeze, given the high cost to borrow and low share availability, with many anticipating substantial long-term value for the low-float stock.

0x (ZRX) is gaining attention following its v2 launch, which enhances swap capabilities and expands its presence across multiple blockchains, coupled with the strategic acquisition of a DEX aggregator. The community actively debates ZRX's foundational utility as "rails" for tokenized assets and major exchanges, with many expressing bullish conviction despite frustration over its price lagging behind other crypto assets. Discussions also highlight the influence of advisor David Sacks, hinting at ZRX's potential in the evolving crypto landscape.

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

BriaCell Therapeutics Corp - Ordinary Shares - New

BriaCell Therapeutics Corp

BriaCell Therapeutics is trending amid intense investor debate following a new public offering and a recent reverse stock split, which have fueled significant frustration over perceived dilution. Counteracting this sentiment, the company has released promising Phase 3 clinical data, secured an NCI grant, and received recognition in Nature Medicine, reinforcing optimism among some about its potential in cancer immunotherapy. The community remains sharply divided between skepticism toward financial management and excitement for the therapeutic pipeline's advancements.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth Inc. is drawing significant attention following the acceleration of its Round Top project timeline to late 2028 and a new supply agreement from its Less Common Metals subsidiary with Solvay. While these developments, along with its impending Russell index inclusion, point to future growth, the community is actively debating perceived stock manipulation and underperformance amidst a broader push for a resilient domestic rare earth supply chain.

Featured in Matt Furies latest book Cortex Vortex as Ratos nemesis. The character is also part of ZOGZ which confirms its real name.  Matt Furie, the artist best known for creating Pepe the Frog, has been working on a new book. The news comes from his editor, who goes by the handle @beuys_on_sale_ on Instagram. In a recent post, the editor hinted at an upcoming project featuring new characters named Gasspas and Rato. Gasspas’s visual appearance can be inferred from the artwork. In one illustration, Gasspas is depicted looming over two rats (Rato and Wat), gazing down at them in a menacing way (an image that has circulated among collectors). This inferred that Gasspas is Ratos nemesis in the new book Cortex Vortex reinforced by community quips that “cats eat rats”. Gasspas debuted as part of ZOGZ, a collection of 111 original NFT character illustrations by Matt Furie launched in May 2023.

Gasspas

Gasspas is trending amidst intense community debate, with many speculating on its potential for significant gains and drawing comparisons to early PEPE due to claims of the same creator, Matt Furie. Enthusiasts are actively 'loading up' and advocating for a 'HODL' strategy to drive a 'community takeover' and 'kill a zero,' while others remain highly skeptical, labeling it a 'scam' or 'junk' and pointing to persistent pump-and-dump patterns.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is experiencing heightened community interest ahead of imminent regulatory milestones, including a PDUFA for tradipitant in motion sickness and ongoing re-review for HETLIOZ in jet lag, following a collaborative agreement with the FDA. Enthusiasm is also fueled by positive data for tradipitant addressing GLP-1 induced nausea and vomiting, positioning the company for potential market expansion and driving discussions around its perceived undervaluation as a high-stakes biotech play.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

On watch tomorrow (momentum) // Part 1 🔥📈📚 
 
$IRBT  
$INHD  
$TDIC  
$WHLR  
$QCLS